Performance analysis of hybrid solar-wind ro-msf desalination system

Introduction: Water, energy, and the environment are three important elements of sustainable development. Production of potable water using desalination technologies powered by renewable energy systems could help solve water scarcity in remote areas with shortages of water or conventional energy sources, or in large cities with air pollution. Hybridization of solar and wind could increase the sustainability and availability of renewable energy sources and reduce energy costs. Additionally, hybridization of reverse osmosis (RO) and MSF could increase efficiency and desalinated water quality and decrease desalinated water cost. Materials and Methods: The research method in this paper is based on modeling, computer simulation, and optimization with MATLAB software, and manufacturing and evaluating the plant at the Tarbiat Modares University Renewable Energy Laboratory. Results: The process of manufacturing the MSF system, solar panel structure, and wind turbine was explained and modeling and optimization results were presented. Testing results of the plant were mentioned, as were the produced power of wind turbine simulated and plant performance evaluated under the environmental conditions of the Tehran region. The rate of fresh water production under changing feed water salinity was evaluated and the real costs of fresh water produced ( Conclusion: Hybridization of RO and MSF systems with wind and solar energy resources led to increased system reliability and flexibility and higher produced drinking water quality. The desalinated water cost was 1.3

Bridging the gap between image coding for machines and humans

Image coding for machines (ICM) aims at reducing the bitrate required to represent an image while minimizing the drop in machine vision analysis accuracy. In many use cases, such as surveillance, it is also important that the visual quality is not drastically deteriorated by the compression process. Recent works on using neural network (NN) based ICM codecs have shown significant coding gains against traditional methods; however, the decompressed images, especially at low bitrates, often contain checkerboard artifacts. We propose an effective decoder finetuning scheme based on adversarial training to significantly enhance the visual quality of ICM codecs, while preserving the machine analysis accuracy, without adding extra bitcost or parameters at the inference phase. The results show complete removal of the checkerboard artifacts at the negligible cost of -1.6% relative change in task performance score. In the cases where some amount of artifacts is tolerable, such as when machine consumption is the primary target, this technique can enhance both pixel-fidelity and feature-fidelity scores without losing task performance

Protective effect of Cortisone and Hydrocortisone drugs on lysosomal damages induced by bacteria endotoxin in wistar rats

Objectives: Bacterial endotoxin as biological stress by multiple organs failure causes lysosomal enzyme leakage. Lysosome as a basic cytoplasmic organelle in animal tissues contains hydrolytic enzymes capable of degrading various cellular constituents. In this study protective effect of Cortisone acetate and hydrocortisone 21-sodium hemisuccinate on lysosomal damage and its association with change level of serum and hepatic acid phosphatase activity investigated. Methods: In this study, 30 rats equally divided to Control, tolerance and Endotoxin groups. The tolerance group (12.5 mg/kg body weight intramuscularly injection Cortisone acetate for 3 days and on the 4th day, the intravenous injection 12.5 mg/kg of hydrocortisone 21-sodium hemisuccinate). The induce endotoxin shock in rats with 2.5 mg/kg body weight intravenous injection of Salmonella endotoxin. Partial purification and beta-glucuronidase activity were determined by sephadexG75 chromatography and Polyacrylamide Gel Electrophoresis. Results: The results of this study shown a significant different in level serum and homogenate acid phosphatse activity in Tolerance group compared with the other groups (P<0.05). Also enzyme especial activity in all steps of purification, in Endotoxin group was more than the other groups (P<0.05). Conclusion: Endotoxin shock as biological stressor by induction of lysosomal enzymes into the cell plays an important role in deterioration of cells. Also, it seems that protection of these particles by injection of cortisone acetate and hydrocortisone 21-sodium hemisuccinate can a significant resistance to induced stress by endotoxin shock

Drug Use among Iranian Drivers Involved in Fatal Car Accidents

Background: Although the problem of substance use among drivers is not limited to certain parts of the world, most epidemiological reports on this topic have been published from industrial world. Aim: To investigate pattern of drug use among Iranian drivers who were involved in fatal road accidents. Methods: This study enrolled 51 Iranian adults who were involved in fatal vehicle accidents and were imprisoned thereafter. Data came from a national survey of drug abuse that was done among Iranian prisoners. The survey collected data at the entry to seven prisons in different regions of the country during a 4-month period in 2008. Self-reported lifetime, last year, and last month drug use was measured. Commercial substance screening tests were applied to detect recent substance use (opioids, cannabinoids, methamphetamines, and benzodiazepines). Results: The commercial substance screening test showed three distinct patterns of recent illicit drug use: opioids (37.3%), cannabinoids (2.0%), opioids and cannabinoids (13.7%). 29.4% were also positive for benzodiazepines. The substance use screening test detected 23.5% of participants who had used drugs but did not disclose any substance use. Conclusion: Opioids are the most common illicit drugs being used by Iranian drivers who are involved in fatal car accidents. The high rate of substance use prior to fatal car accidents in Iran advocates for the need for drug use control policies and programs as major strategies for injury prevention in Iran. There is also a need for substance screening among all drivers involved in fatal car accidents in Iran, as more than 20% of users may not disclose substance use

Adaptation and Attention for Neural Video Coding

Neural image coding represents now the state-of-The-Art image compression approach. However, a lot of work is still to be done in the video domain. In this work, we propose an end-To-end learned video codec that introduces several architectural novelties as well as training novelties, revolving around the concepts of adaptation and attention. Our codec is organized as an intra-frame codec paired with an inter-frame codec. As one architectural novelty, we propose to train the inter-frame codec model to adapt the motion estimation process based on the resolution of the input video. A second architectural novelty is a new neural block that combines concepts from split-Attention based neural networks and from DenseNets. Finally, we propose to overfit a set of decoder-side multiplicative parameters at inference time. Through ablation studies and comparisons to prior art, we show the benefits of our proposed techniques in terms of coding gains. We compare our codec to VVC/H.266 and RLVC, which represent the state-of-The-Art traditional and end-To-end learned codecs, respectively, and to the top performing end-To-end learned approach in 2021 CLIC competition, E2E_T_OL. Our codec clearly outperforms E2E_T_OL, and compare favorably to VVC and RLVC in some settings.acceptedVersionPeer reviewe

Adaptation and Attention for Neural Video Coding

Neural image coding represents now the state-of-The-Art image compression approach. However, a lot of work is still to be done in the video domain. In this work, we propose an end-To-end learned video codec that introduces several architectural novelties as well as training novelties, revolving around the concepts of adaptation and attention. Our codec is organized as an intra-frame codec paired with an inter-frame codec. As one architectural novelty, we propose to train the inter-frame codec model to adapt the motion estimation process based on the resolution of the input video. A second architectural novelty is a new neural block that combines concepts from split-Attention based neural networks and from DenseNets. Finally, we propose to overfit a set of decoder-side multiplicative parameters at inference time. Through ablation studies and comparisons to prior art, we show the benefits of our proposed techniques in terms of coding gains. We compare our codec to VVC/H.266 and RLVC, which represent the state-of-The-Art traditional and end-To-end learned codecs, respectively, and to the top performing end-To-end learned approach in 2021 CLIC competition, E2E_T_OL. Our codec clearly outperforms E2E_T_OL, and compare favorably to VVC and RLVC in some settings.acceptedVersionPeer reviewe

Learned Enhancement Filters for Image Coding for Machines

Machine-To-Machine (M2M) communication applications and use cases, such as object detection and instance segmentation, are becoming mainstream nowadays. As a consequence, majority of multimedia content is likely to be consumed by machines in the coming years. This opens up new challenges on efficient compression of this type of data. Two main directions are being explored in the literature, one being based on existing traditional codecs, such as the Versatile Video Coding (VVC) standard, that are optimized for human-Targeted use cases, and another based on end-To-end trained neural networks. However, traditional codecs have significant benefits in terms of interoperability, real-Time decoding, and availability of hardware implementations over end-To-end learned codecs. Therefore, in this paper, we propose learned post-processing filters that are targeted for enhancing the performance of machine vision tasks for images reconstructed by the VVC codec. The proposed enhancement filters provide significant improvements on the target tasks compared to VVC coded images. The conducted experiments show that the proposed post-processing filters provide about 45% and 49% Bjontegaard Delta Rate gains over VVC in instance segmentation and object detection tasks, respectively.acceptedVersionPeer reviewe

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Background: Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternative scenarios assessing disease burden trajectories if selected sets of risk factors were eliminated from current levels by 2050. Methods: Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income per capita, mean years of education, and total fertility under 25 years of age) and the full set of risk factor exposures captured by GBD, we provide cause-specific forecasts of mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) by age and sex from 2022 to 2050 for 204 countries and territories, 21 GBD regions, seven super-regions, and the world. All analyses were done at the cause-specific level so that only risk factors deemed causal by the GBD comparative risk assessment influenced future trajectories of mortality for each disease. Cause-specific mortality was modelled using mixed-effects models with SDI and time as the main covariates, and the combined impact of causal risk factors as an offset in the model. At the all-cause mortality level, we captured unexplained variation by modelling residuals with an autoregressive integrated moving average model with drift attenuation. These all-cause forecasts constrained the cause-specific forecasts at successively deeper levels of the GBD cause hierarchy using cascading mortality models, thus ensuring a robust estimate of cause-specific mortality. For non-fatal measures (eg, low back pain), incidence and prevalence were forecasted from mixed-effects models with SDI as the main covariate, and YLDs were computed from the resulting prevalence forecasts and average disability weights from GBD. Alternative future scenarios were constructed by replacing appropriate reference trajectories for risk factors with hypothetical trajectories of gradual elimination of risk factor exposure from current levels to 2050. The scenarios were constructed from various sets of risk factors: environmental risks (Safer Environment scenario), risks associated with communicable, maternal, neonatal, and nutritional diseases (CMNNs; Improved Childhood Nutrition and Vaccination scenario), risks associated with major non-communicable diseases (NCDs; Improved Behavioural and Metabolic Risks scenario), and the combined effects of these three scenarios. Using the Shared Socioeconomic Pathways climate scenarios SSP2-4.5 as reference and SSP1-1.9 as an optimistic alternative in the Safer Environment scenario, we accounted for climate change impact on health by using the most recent Intergovernmental Panel on Climate Change temperature forecasts and published trajectories of ambient air pollution for the same two scenarios. Life expectancy and healthy life expectancy were computed using standard methods. The forecasting framework includes computing the age-sex-specific future population for each location and separately for each scenario. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline. Findings: In the reference scenario forecast, global and super-regional life expectancy increased from 2022 to 2050, but improvement was at a slower pace than in the three decades preceding the COVID-19 pandemic (beginning in 2020). Gains in future life expectancy were forecasted to be greatest in super-regions with comparatively low life expectancies (such as sub-Saharan Africa) compared with super-regions with higher life expectancies (such as the high-income super-region), leading to a trend towards convergence in life expectancy across locations between now and 2050. At the super-region level, forecasted healthy life expectancy patterns were similar to those of life expectancies. Forecasts for the reference scenario found that health will improve in the coming decades, with all-cause age-standardised DALY rates decreasing in every GBD super-region. The total DALY burden measured in counts, however, will increase in every super-region, largely a function of population ageing and growth. We also forecasted that both DALY counts and age-standardised DALY rates will continue to shift from CMNNs to NCDs, with the most pronounced shifts occurring in sub-Saharan Africa (60·1% [95% UI 56·8–63·1] of DALYs were from CMNNs in 2022 compared with 35·8% [31·0–45·0] in 2050) and south Asia (31·7% [29·2–34·1] to 15·5% [13·7–17·5]). This shift is reflected in the leading global causes of DALYs, with the top four causes in 2050 being ischaemic heart disease, stroke, diabetes, and chronic obstructive pulmonary disease, compared with 2022, with ischaemic heart disease, neonatal disorders, stroke, and lower respiratory infections at the top. The global proportion of DALYs due to YLDs likewise increased from 33·8% (27·4–40·3) to 41·1% (33·9–48·1) from 2022 to 2050, demonstrating an important shift in overall disease burden towards morbidity and away from premature death. The largest shift of this kind was forecasted for sub-Saharan Africa, from 20·1% (15·6–25·3) of DALYs due to YLDs in 2022 to 35·6% (26·5–43·0) in 2050. In the assessment of alternative future scenarios, the combined effects of the scenarios (Safer Environment, Improved Childhood Nutrition and Vaccination, and Improved Behavioural and Metabolic Risks scenarios) demonstrated an important decrease in the global burden of DALYs in 2050 of 15·4% (13·5–17·5) compared with the reference scenario, with decreases across super-regions ranging from 10·4% (9·7–11·3) in the high-income super-region to 23·9% (20·7–27·3) in north Africa and the Middle East. The Safer Environment scenario had its largest decrease in sub-Saharan Africa (5·2% [3·5–6·8]), the Improved Behavioural and Metabolic Risks scenario in north Africa and the Middle East (23·2% [20·2–26·5]), and the Improved Nutrition and Vaccination scenario in sub-Saharan Africa (2·0% [–0·6 to 3·6]). Interpretation: Globally, life expectancy and age-standardised disease burden were forecasted to improve between 2022 and 2050, with the majority of the burden continuing to shift from CMNNs to NCDs. That said, continued progress on reducing the CMNN disease burden will be dependent on maintaining investment in and policy emphasis on CMNN disease prevention and treatment. Mostly due to growth and ageing of populations, the number of deaths and DALYs due to all causes combined will generally increase. By constructing alternative future scenarios wherein certain risk exposures are eliminated by 2050, we have shown that opportunities exist to substantially improve health outcomes in the future through concerted efforts to prevent exposure to well established risk factors and to expand access to key health interventions

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021. METHODS: We estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined. FINDINGS: Globally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer. INTERPRETATION: As the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed